This study identifies three novel blood-based DNA methylation markers for cIMT using an Asian-led, trans-ancestry discovery strategy; among these, cg08227773 showed causal-inference evidence consistent with methylation-mediated effects on CAD risk and with regulation of NBEAL2 expression. The gene discussed is NBEAL2; the disease is coronary artery disorder.